In a National Institutes of Health (NIH)-funded study, researchers developed a cancer assessment tool that can identify high-risk patients and the tumor cells linked to that risk.
Read exclusive expert insight from ESCMID Global 2026, on leveraging AI to combat the ever-growing AMR crisis.
Antimicrobial resistance (AMR) is an urgent and growing concern in global health, threatening the effectiveness of antibiotics and the management of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results